HRT Financial’s Soleno Therapeutics SLNO Stock Holding History

HRT Financial’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,247	Closed	-$376K	–	5241
2026 Q1	$376K	Buy	11,247 +6,463	+135%	+$253K	﹤0.01%	2719
2025 Q4	$221K	Buy	+4,784	New	+$262K	﹤0.01%	2565
2022 Q3	–	Sell	-3,182	Closed	-$8K	–	3441
2022 Q2	$8K	Buy	+3,182	New	+$8.81K	﹤0.01%	2705

HRT Financial's SLNO Position: Q2 2026 in Review

HRT Financial sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 11,247 shares — an estimated $376K sold.

HRT Financial first reported a position in SLNO in Q2 2022 and held it in 3 quarters. The position peaked at $376K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

HRT Financial reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 11,247 Soleno Therapeutics shares in Q2 2026, an estimated $376K.
HRT Financial first reported a position in Soleno Therapeutics in Q2 2022 and held it in 3 quarters.
HRT Financial's Soleno Therapeutics position peaked at $376K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.